Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $4.5 million, a decrease of approximately 23% compared to $5.8 million in Q1 2024, primarily due to the discontinuation of TrustCo's operations and a softening of customer shipments [4][12] - Gross profit decreased by $800,000 to $1.5 million in Q1 2025 from $2.3 million in Q1 2024, with gross margin at 33% compared to 39% in the prior year [12][13] - Operating expenses were reduced by approximately 28% to $2.1 million in Q1 2025 from $2.9 million in Q1 2024, helping to offset the decrease in gross margin [5][13] - The net loss for the quarter was $600,000, or a loss of $0.05 per diluted share, consistent with Q1 2024 [13] Business Line Data and Key Metrics Changes - The decline in revenue was most pronounced in premium services, which were down 47% compared to the same quarter last year [4] - Improvements in gross margin were noted in proactive services within the Precision Logistics segment, which is viewed as a key area for organic growth [5] Market Data and Key Metrics Changes - The overall market environment remains challenging, with a noted softening in customer demand across several proactive customers, particularly in e-commerce [46] - New customer additions have slowed down, and existing customers are experiencing a softening in demand, impacting overall revenue [45][46] Company Strategy and Development Direction - The company is focusing on three elements for organic growth: optimizing direct customer marketing and sales, developing relationships with additional freight carriers, and integrating with technology platforms related to e-commerce [7][9] - Strategic growth efforts include pursuing transformative and tuck-in acquisitions, leveraging the strong balance sheet and cash flow to create shareholder value [10][49] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the current macroeconomic challenges but remains optimistic about the company's ability to create shareholder value through strategic initiatives and a strong cash position [6][54] - The company is focused on maximizing upside opportunities in a changing logistics marketplace, which is becoming more receptive to new ideas and partnerships [55][56] Other Important Information - The company had a cash balance of $5.7 million at the end of Q1 2025, with no bank debt and only $800,000 remaining on convertible notes held by insiders [6][14] - Nancy Meyers, the CFO, announced her retirement, with Jennifer Colo set to take over the role [16][19] Q&A Session Summary Question: What are the capital allocation priorities moving forward? - The company is prioritizing organic growth investments funded by business operations, with a focus on integrating with e-commerce platforms and expanding customer relationships [24][26] Question: What is the revenue generation for the authentication business in the quarter? - The revenue for the authentication business was $26,000 [31] Question: Should revenue comparisons be expected to improve in the second half of the year? - Revenue comparisons are expected to remain challenging in Q2, with hopes for improvement in the second half of the year [35][38] Question: How are new customers performing and what is the outlook for existing customers? - New customer additions have slowed, and existing customers are experiencing a softening in demand, impacting overall revenue [45][46] Question: What is the latest update on the ink business and strategic discussions? - The company is exploring potential acquisitions that could synergize with its ink business, but the focus remains on opportunities within Precision Logistics [49]

Financial Data and Key Metrics Changes - First quarter revenue increased by 4% to $1.5 billion compared to the prior year, driven by a 2.7% growth in adjusted admissions and a 1.2% increase in net patient service revenue per adjusted admission [11][12] - Adjusted EBITDA grew by 2.5% to $98 million, with supply costs as a percentage of revenue declining by 60 basis points year over year [7][16] - Total cash at the end of the first quarter was $495 million, with total debt outstanding at $1.1 billion, resulting in a total available liquidity of $790 million [16][17] Business Line Data and Key Metrics Changes - Admissions grew by 7.6%, with inpatient surgery growth at 3.4%, while outpatient surgeries declined by 2.3% [5][12] - The growth rate of physician professional fees was 6%, down from 13% in the same period last year, indicating a moderation in cost growth [7][63] - The integration of 18 NexCare Urgent Care clinics is expected to generate additional downstream volumes in the Tulsa and Albuquerque markets [8] Market Data and Key Metrics Changes - The company is experiencing strong demand in its existing markets, with an average market growth rate of about 3% per year [40] - Exchange volume growth was significant, with admissions in the quarter growing by 40%, contributing to mid-single digits as a percentage of revenue [60] Company Strategy and Development Direction - The company is focused on expanding its outpatient and acute care hospital footprint, supported by approximately $500 million in cash and a favorable lease-adjusted net leverage ratio of three times [4][9] - A disciplined approach to evaluating M&A opportunities is being pursued, with increased interest in the company's joint venture model from potential academic and non-profit partners [8][9] - The company aims to achieve margin expansion of 100 to 200 basis points over the next several years through operational initiatives and supply chain efficiencies [7][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the durability of demand, attributing strong volume growth to operational improvements and the strength of the markets [40] - The company reaffirmed its full-year 2025 financial guidance, indicating a solid start to the year and strong momentum [9][17] - Management noted that while payer claim denials have increased, they do not expect a significant impact compared to the latter half of 2024 [13][28] Other Important Information - The company is in the final stages of recruiting a Chief Development Officer to support its focus on M&A activities [4] - S&P upgraded the company's credit rating to B+ from B, reflecting improved net leverage and cash flow profile [17] Q&A Session Summary Question: Inquiry about seasonality and EBITDA decline - Management indicated that a sequential decline in EBITDA is not abnormal and attributed it to various factors including flu season impacts and timing issues [22][26] Question: Follow-up on elevated denials - Management confirmed that the increase in denials is consistent with previous trends and highlighted a slowdown in payments on clean claims [28][29] Question: Supply chain initiatives and opportunities - Management noted participation in a GPO and ongoing improvements in service line utilization as key areas for margin expansion [30][31] Question: Update on expansion initiatives - Management reported a growing pipeline for new market opportunities and emphasized the importance of strategic acquisitions [46][53] Question: New Mexico DPP program approval timeline - Management expressed hope for approval by the end of Q2, based on positive indications from state and CMS conversations [54][56] Question: Exchange volumes and payer mix - Management confirmed strong exchange growth, with admissions increasing significantly and operating in mid-single digits as a percentage of revenue [60]